XML 37 R14.htm IDEA: XBRL DOCUMENT v3.19.1
Note 8 - Stockholders' Equity
12 Months Ended
Dec. 31, 2018
Notes to Financial Statements  
Shareholders' Equity and Share-based Payments [Text Block]
8.
Stockholders’ Equity
 
Stock Options – Incentive Stock Plans
 
The Company sponsors an incentive stock plan (the
“2014
Plan”) allowing for a maximum of
142,857
shares to be granted in the form of either incentive stock options, non-qualified stock options, restricted stock awards, or unrestricted stock awards. Employees, directors, advisors, and consultants of the Company are eligible to receive the grants. This plan has been approved by the stockholders of the Company. The Compensation Committee of the Board of Directors administers the plan.
 
The
2014
Plan provides that options
may
be issued under the Plan at an option price
not
less than fair market value of the stock at the time the option is granted. Under the plan, restricted stock of the Company
may
be granted at
no
cost to the grantee. The grantees are entitled to dividends and voting rights for their respective shares. Restrictions limit the sale or transfer of these shares during the requisite service period. In addition, the committee
may
grant or sell unrestricted stock at a purchase price to be determined by the committee. Vesting terms and restrictions, if applicable, under the plan, are set by the committee and will be
10
years or less. The
2014
Plan expires in
2024.
 
In
May 2017,
the Company’s shareholders voted to approve a
2017
Incentive Stock Plan (
2017
Plan) which authorizes the issuance of up to
200,000
shares of the Company’s common stock in various forms of stock options and/or stock awards. The
2017
Plan will
not
become effective until registered with the Securities and Exchange Commission.
 
A summary of the Company’s stock option activity and related information for the years ended
December 31
follows:
 
   
2018
   
2017
 
   
Options
   
Weighted
Avg.
Exercise
Price
   
Options
   
Weighted
Avg.
Exercise
Price
 
Outstanding beginning of the year
 
 
140,424
   
$
7.85
     
236,844
    $
$8.14
 
Granted
 
 
-
     
 
     
-
     
 
 
Exercised
 
 
-
     
 
     
-
     
 
 
Expired and forfeited
 
 
(58,998
)
 
 
7.96
     
(96,420
)    
8.57
 
Outstanding at end of year
 
 
81,426
   
$
7.77
     
140,424
    $
7.85
 
                                 
Exercisable at end of year
 
 
14,655
   
$
7.77
     
13,713
    $
7.77
 
 
Compensation cost for the stock option plan was approximately
$21,000
(
$21,000
net of tax) and
$27,000
(
$27,000
net of tax) for the years ended
December 31, 2018
and
2017,
respectively, and has been recorded in selling, general, and administrative expense. As of
December 31, 2018,
the total remaining unrecognized compensation cost related to the non-vested portion of time vesting stock options totaled
$19,000
(
$19,000
net of tax), which will be amortized over the weighted remaining requisite service period of
1.17
years. The aggregate intrinsic value of stock options outstanding and currently exercisable at
December 31, 2018
was $-
0
-.
 
Distributor Stock Purchase Plan
 
In
July 2009,
the Company established a Distributor Stock Purchase Plan (
2009
Plan) which replaced a similar plan which had expired.
 
The plan allows distributors who have reached the “Ambassador” status the opportunity to allocate up to
10%
of their monthly compensation into the plan to be used to purchase the Company’s common stock at the current market value. The plan also states that at the end of each year, the Company will grant warrants to purchase additional shares of the Company’s common stock based on the number of shares purchased by the distributors under the plan during the year. The warrant exercise price will equal the market price for the Company’s common stock at the date of issuance. The warrants issued shall be in the amount of
25%
of the total shares purchased under the plan during the year and the warrants are fully vested upon grant.
 
The Company records expense under the fair value method for warrants granted to distributors. Total expense for the warrants was
$3,000
and
$6,600
in
2018
and
2017,
respectively.
 
A summary of the Company’s warrant activity for the years ended
December 31
follows:
 
   
2018
   
2017
 
   
Warrants
   
Weighted
Avg.
Exercise
Price
   
Warrants
   
Weighted
Avg.
Exercise
Price
 
                                 
Outstanding beginning of the year
 
 
5,960
   
$
4.46
     
6,291
    $
5.34
 
Granted
 
 
1,113
   
 
4.24
     
1,258
     
4.77
 
Exercised
 
 
-
     
 
     
-
     
 
 
Expired
 
 
(2,183
)
 
 
4.06
     
(1,589
)    
8.19
 
Outstanding at end of year
 
 
4,890
   
$
4.58
     
5,960
    $
4.46
 
                                 
Exercisable at end of year
 
 
4,890
     
 
     
5,960
     
 
 
 
 
 
 
 
 
As of December 31, 2018
 
 
 
 
 
 
Warrants Outstanding and Exercisable
 
Range of
Exercise Prices
   
Warrants
   
Weighted
Avg. Exercise
Price
   
Weighted
Avg. Remaining
Life
 
 
$4.24
 
     
1,113
    $
4.24
     
3.00
 
 
$4.64
 
     
2,519
     
4.64
     
1.00
 
 
$4.77
 
     
1,258
     
4.77
     
2.00
 
$4.24
-
$4.77
     
4,890
    $
4.58
     
1.71
 
 
The fair value of the warrants was estimated at the date of grant using a Black-Scholes option pricing model with the following assumptions:
 
   
Year ended December 31
 
   
2018
   
2017
 
                 
Expected warrant life (years)
 
 
3.0
     
3.0
 
Risk-free weighted average interest rate
 
 
2.46
%
   
1.98
%
Stock price volatility
 
 
55.8
%
   
73.8
%
Dividend yield
 
 
0.0
%
   
0.0
%
 
The intrinsic value for stock warrants outstanding at
December 31, 2018
was $-
0
-.
 
The
2009
Distributor Stock Purchase Plan was established with a
ten
-year life. As a result, there will be
no
further grants from this Plan. Upon exercise, forfeiture or expiration of all outstanding warrants, the Plan will terminate.